Illumina Partners with Merck to Develop and Commercialize Companion Diagnostic and Research Tests for Use in Identifying Specific Cancer Mutations

Sep 7, 2021 SAN DIEGO, Sept. 7, 2021 /PRNewswire/ — Illumina, Inc. (NASDAQ: ILMN) and Merck (known as MSD outside the United States and Canada) today announced a partnership to develop and commercialize tests that identify genetic mutations used in the assessment of homologous recombination deficiency (HRD). Patients whose tumors are HRD-positive may be eligible for... Read more

Illumina Acquires GRAIL to Accelerate Patient Access to Life-Saving Multi-Cancer Early-Detection Test

Sep 7, 2021 SAN DIEGO, Sept. 7, 2021 /PRNewswire/ — Illumina, Inc. (NASDAQ: ILMN) and Merck (known as MSD outside the United States and Canada) today announced a partnership to develop and commercialize tests that identify genetic mutations used in the assessment of homologous recombination deficiency (HRD). Patients whose tumors are HRD-positive may be eligible for... Read more

Speeding up Breast Cancer Diagnosis in Egypt: GE Healthcare, Gustave Roussy and the Egypt Ministry of Health Partner to Create Rapid Breast Cancer Diagnosis Clinics

Cairo, Egypt and Villejuif & Buc, France – September 7, 2021 – GE Healthcare, Gustave Roussy and the Egypt Ministry of Health (MOH) signed a preliminary agreement leveraging Gustave Roussy’s One Stop Breast Cancer diagnostics program to increase the speed and the accuracy of breast cancer diagnosis in Egypt. Breast cancer is the most common... Read more

Completion of the Acquisition of WITec

Oxford Instruments plc, a leading provider of high-technology solutions, information and services for industry and research is pleased to confirm the completion of the acquisition of WITec Wissenschaftliche Instrumente und Technologie GmbH and all its Group companies, following regulatory approval from the Federal Ministry for Economic Affairs and Energy (BMWi) in Germany and satisfaction of... Read more

Divestment of NDC Technologies

24 August 2021 – Spectris plc (SXS: LSE), the expert in providing insight through precision measurement, today announces the divestment of its NDC Technologies (‘NDC’) business. The transaction is in line with Spectris’ strategy to simplify and focus its portfolio and is the last of the divestments identified in 2019 as part of its Strategy... Read more

Thermo Fisher Scientific Collaborates with ChromSword to Deliver Rapid Automated HPLC and UHPLC Method Development System

Thermo Fisher Scientific Collaborates with ChromSword to Deliver Rapid Automated HPLC and UHPLC Method Development System GERMERING, Germany, Aug. 16, 2021 /PRNewswire/ — Thermo Fisher Scientific, the world leader in serving science, and ChromSword, a provider of innovative software products, have collaborated to launch an automated high performance liquid chromatography (HPLC) and ultra-high performance liquid... Read more

GE Healthcare Announces Strategic Collaboration Agreement with AWS to Transform Care Delivery and Help Clinicians Improve Patient Care

 GE Healthcare Announces Strategic Collaboration Agreement with AWS to Transform Care Delivery and Help Clinicians Improve Patient Care  ·       GE Healthcare to make imaging applications, healthcare workflows, and data and analytics more accessible to benefit medical professionals, AI developers, and patients ·       Helps the healthcare industry transition to a virtualized and distributed care model by... Read more

Rigaku Acquires Life Science Imaging Equipment Manufacturer MILabs

Full-Scale Entry into the Global Life Sciences Business Rigaku Corporation (Headquarters: Akishima-shi, Tokyo; President: Toshiyuki Ikeda; “Rigaku”), a leading manufacturer of X-ray analysis equipment, has acquired all issued shares of MILabs B.V. (Headquarters: Houten, The Netherlands; CEO and CSO: Dr. Frederik Beekman; “MILabs”) on August 2, 2021, as part of their full-scale effort to enter... Read more

Abcam to acquire BioVision for $340 million

2 August 2021, Cambridge, UK  – Abcam plc (“Abcam”, “the Company” or “the Group”) (AIM LSE: ABC; Nasdaq: ABCM), a global leader in the supply of life science research tools, announces that it has entered into a definitive agreement to acquire BioVision, Inc. (“BioVision”), a wholly owned subsidiary of Boai NKY Medical Holdings Ltd. (“NKY”), for... Read more

Tecan successfully completes the acquisition of Paramit

Ad hoc announcement pursuant to Article 53 of the SIX Exchange Regulation Listing Rules Männedorf, Switzerland, August 2 2021 – The Tecan Group (SIX Swiss Exchange: TECN) announced today that it has successfully completed the acquisition of US-based Paramit Corporation and its affiliates (“Paramit”) for a total purchase consideration of USD 1.0 billion (CHF 920 million). On June 23, 2021, Tecan... Read more